A detailed history of Integral Health Asset Management, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 275,000 shares of ARWR stock, worth $5.8 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
275,000
Holding current value
$5.8 Million
% of portfolio
0.46%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$17.7 - $26.34 $4.87 Million - $7.24 Million
275,000 New
275,000 $5.17 Million
Q1 2022

May 12, 2022

SELL
$39.62 - $69.97 $1.98 Million - $3.5 Million
-50,000 Closed
0 $0
Q4 2021

Feb 02, 2022

BUY
$58.09 - $82.51 $2.9 Million - $4.13 Million
50,000 New
50,000 $3.32 Million
Q1 2021

May 10, 2021

SELL
$61.35 - $90.47 $3.07 Million - $4.52 Million
-50,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$43.82 - $85.37 $2.19 Million - $4.27 Million
50,000 New
50,000 $3.84 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.23B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.